Analyst Ratings for Allscripts Healthcare Solutions Inc. (MDRX)

Updated: 2017-07-26

Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, MDRX was issued an average rating of Overweight.

9 analysts declared MDRX a buy, 2 gave an overweight rating, 14 issued a hold rating, 0 issued an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for MDRX. The maximum price target given was 17, implying a possible profit of 35.89 percent. The most pessimistic analyst gave a price target of 11, which equates to a potential downside of -12.07 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes 0 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 3.26 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.

MDRX has traded between a high of 15.17 and a low of 9.80 over the past year. Today's price is 27.65 percent above the 52-week low, and 17.53 percent below the high. MDRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDRX value stock report compares MDRX to some of its peers using value stock charts. The market cap of MDRX is $2.25 billion. MDRX's next earnings release will be on 0000-00-00, which is days away.